Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
EBITDAEPS (Basic)EPS (Weighted Average and Diluted)Interest & Investment IncomeInterest ExpensesInterest ExpensesNon Operating IncomeOperating ExpensesOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Achieve Life Sciences (ACHV) Non Operating Income (2016 - 2026)

Achieve Life Sciences (ACHV) has disclosed Non Operating Income for 17 consecutive years, with -$13000.0 as the latest value for Q1 2026.

  • Quarterly Non Operating Income fell 161.9% to -$13000.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $152000.0 through Mar 2026, down 71.37% year-over-year, with the annual reading at $232000.0 for FY2025, 873.33% up from the prior year.
  • Non Operating Income for Q1 2026 was -$13000.0 at Achieve Life Sciences, down from $69000.0 in the prior quarter.
  • The five-year high for Non Operating Income was $1.2 million in Q4 2022, with the low at -$2.5 million in Q4 2023.
  • Average Non Operating Income over 5 years is -$154764.7, with a median of -$13000.0 recorded in 2026.
  • The sharpest move saw Non Operating Income surged 3488.89% in 2022, then crashed 16966.67% in 2024.
  • Achieve Life Sciences' Non Operating Income stood at $1.2 million in 2022, then plummeted by 308.11% to -$2.5 million in 2023, then skyrocketed by 121.98% to $558000.0 in 2024, then plummeted by 87.63% to $69000.0 in 2025, then plummeted by 118.84% to -$13000.0 in 2026.
  • Per Business Quant, the three most recent readings for ACHV's Non Operating Income are -$13000.0 (Q1 2026), $69000.0 (Q4 2025), and $251000.0 (Q3 2025).